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abstract The determination of residual solvents in drug substances is the 
mandatory requirement by various health authorities in the world. There 
are no analytical methods available in the literature that can simultaneously 
separate and quantitate residual solvents in bromohexine hydrochloride 
(BHX) active pharmaceutical ingredient (API). This paper describes the 
developmentand validation of a simple, efficient, accurate and robust static 
headspace gas chromatography method forthe determination of residual 
solvents, namely methanol, ethanol, ethyl acetate, monochlorobenzene and 
benzene, in BHXAPI.This new method has been demonstrated to beaccurate, 
linear, precise, reproducible, specific and robust for its intended purpose.The 
method give very good sensitivities viz. detection limits for benzene is 0.4 
ppm, ethyl acetate 2 ppm  and for others solvents 5 ppm and precision (below 
9.0 % RSD) for all solvents. The results of this evaluation stronglyindicate 
that this method can be readily used to determine residual solvents in BHX.
Keywords: Residual solvents, Static Headspace Gas chromatography, 
Method Validation, Bromhexine hydrochloride, Active pharmaceutical 
ingredient (API)
1. intRoDuCtion
The residual solvents (RS) are potentially undesirable substances present in APIs. They either modify the properties of certain compounds and also hazardous to the health of the individual(Puranik et al. 2008;Guyot-
Hermann, 1991;Devotta et al. 1995;Witschi & Doelker, 1997) mentioned 
thatthe presence of RS in an API affects the physiochemical properties (i.e., 
physicalforms) and or physical appearance and other characteristics(e.g., 
color, odor, etc.) of the bulk API. As such, appropriateattempts are always 






taken in the manufacturing of APIs (such asdrying) to eliminate and or 
minimize the presence of RS in the bulklots of APIs. However, depending 
on the characteristics of the API,RS, and drying conditions/parameters of the 
API, various levels ofRS can be retained in the final bulk lots of APIs. Hence 
evaluation of RS in drug substances, excipients or drug products is one of the 
most difficult and demanding analytical task in pharmaceutical industry.
RS are divided into four different classes according to the guidelines of 
International Conference on Harmonization(ICH, 1997 &2002), frommost 
toxic solvents to solvents with insignificant toxicologicaleffect on human 
health. Over, the last decade, gas chromatography have became the most 
practical and popular techniques to analyze the content of residual solvents 
in APIs (Pandey et al.2011).The sampling techniques usingstatic headspace 
gas chromatography (HSGC) gained preferenceand popularity over the direct 
injection GC because of various complicationsand disadvantages caused by 
the direct injection of theAPI into the GC system (B’Hymer, 2003). HSGC 
methods minimize any potentialinterference caused by non-volatile substances 
(or by the degradation/decomposition products of the non-volatile components) 
as aresult of direct injection into the GC system. Further, the directinjection 
method requires relatively high sample concentration,and this often leads to 
poor chromatography (for capillary columns)and limited injections of samples 
per sequence of sample analysis.Consequently, HSGC with FID detection has 
been widely used by different workers (Kolb& Ettre,1991;Mulligan&McCauley, 
1995;Camarasuet al. 1998;QinL et al. 2004;Oteroet al. 2004;Yarramrajuet al. 
2007;Lauset al.2009) forthe analysis of organic volatile ingredients present in 
API and drug products.
Bromhexine Hydrochloride (BHX) is a mucolytic agent used in the 
treatment of respiratory tract infections like acute tracheobronchitis, chronic 
bronchitis, bronchial asthma, and chronic sinusitis etc. It is secretolytic i.e. it 
increases the production of serous mucus in the respiratory tract and makes 
the phlegm thinner and less sticky. This contributes to a secretomotoric effect 
and helps the cilia (tiny hairs that line the respiratory tract) to transport the 
phlegm out of the lungs.The general procedure of Ph. Eur. and USP for RS 
determinationin pharmaceutical products includes analysis of many solvents 
andhence a longer GC cycle time. However, in the manufacturing of BHX 
only a handful of the solvents were used so our objective was to develop 
a simple, robust and efficientHSGC method that can accurately quantitate 
all the five RS present in commercial lots of BHX API.The present work 
describes the developmentand validation of an efficient, accurate, sensitive 
and rugged HSGC method for quantitationof RS present in commercial bulk 
BHX API.
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The active substance – Bromhexine hydrochloride was synthesized in the R&D 
lab of Aanjaneya Lifecare. Ltd. Mahad, Maharashtra India. Analytical grade 
solvents viz., methanol, ethanol, ethyl acetate, benzene and monochlorobenzene 
were procured from Merck (Mumbai, India) and dimethylsulfoxide (DMSO) 
from Rankem (Delhi, India).
2.2 instrumentation
Method development and validation was performed using a Shimadzu GC-
2014 equipped with standard oven for temperature ramping, split/splitless 
injection ports and flame ionization detector (FID), a data system capable 
of performing data collection and integration and headspace auto sampler of 
Teledyne Tekmar capable of housing 10 ml GC headspace vials (versa).
2.3 Chromatographic conditions
Separation was performed on Rtx-1301, 30.0 m X 3.0 mm ID, 3.0 µm 
film thickness cross bonded (6% cyanopropyl phenyl and 94% dimethyl 
polysiloxane) column manufactured by Restek Bellefone, USA. The GC 
parameter, headspace parameter and temperature programming of the method 
are given in Table-1.
2.4 Preparation of standard stock solution
Standard stock solution of all five solvents viz., methanol, ethanol, ethyl 
acetate, benzene and monochlorobenzene was prepared in dimethylsulfoxide 
(DMSO) and was 200 ppm for benzene and 5000 ppm for the rest solvents.
2.5 Mixed standard preparation
Transferred 1.0 ml of each standard stock solution in to a 100.0 ml volumetric 
flask and diluted to volume with diluent. The prepared solution was equivalent 
to 2 ppm for benzene and 50 ppm for the rest solvents.
2.6 Sample Preparation 
Weighed accurately about 1.0 gm of bromhexine hydrochloride and transferred 
into a vial, added 5 ml of diluent mixed well and sealed the vial with septum 
and metallic cap. Bromhexine hydrochloride dissolves completely at the 
sample oven temperature of 80 °C.






table 1. GC parameters, headspace parameters and temperature 
programming for GC column.
GC Parameters
GC Column RTX-1301, 30.0 m X 0.53 mm ID, 3.0 µm film 
thickness
Carrier gas Nitrogen 3.0 ml/min. (constant flow)
Inlet Temperature 160 °C
Detector Flame Ionization Detector (FID), 260 °C
Hydrogen 40 ml/min
Air  300 ml/min
Make-up gas 40 ml/min
Inlet split ratio 20:1
Headspace Parameters
GC Cycle time 38.00 min
Valve Oven temp. 80.0 °C
Transfer Line Temp. 85 °C
Platen/sample Temp. 80.0 °C
Platen Temp. Equil. Time 0.5 min
Sample Equil. Time 30.00 min
Mixer On
Mixing Level Medium
Mixing Time 1.00 min
Mixer Stabilize Time 0.20 min
Pressurize 15.0 psig
Pressurize Time 2.00 min
Pressurize Equil. Time 0.25 min
Loop Fill Pressure 5.0 psig
Loop Fill Time 2.00 min
Inject Time 1.00 min
Sample Loop Size 1.0 ml
temperature programming for the GC column
Temperature(°C) Hold(min) Ramp(°C/min)
Initial Temperature 40.0 °C 7.0 15.0
Temperature I 230.0 °C 5.0 --
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The validation parameters addressed were specificity, precision, linearity, 
and detectionlimit, quantitationlimit, robustness and system suitability. After 
equilibrating the column, system blank and blank solution (diluent) were 
run and correction made accordingly. The vials of standard and test solution 
were loaded into the headspace oven and heated for 10 minutes to ensure 
liquid-gas equilibrium of the residual solvents. The resulting samples were 
injected into the GC system via a 1-ml sample loop. The linearity study for 
all the five solvents was carried out both in the presence and absence of 
bromhexine hydrochloride. The linearity study in the absence of bromhexine 
hydrochloride was carried out from 1.6 to 2.4 ppm for benzene and from 40-
60 ppm for the remaining residual solvents. The linearity/accuracy/precision 
study in the presence of bromhexine hydrochloride (spiked API samples) 
was carried out from1.6 to 2.4 ppm for benzene and from 40-60 ppm for 
the remaining residual solvents. RS spiked API samples were prepared by 
pipetting 1.0 ml of appropriate linearity standard solutions into 10.0 ml 
headspace vials containing 1.0 gm of bromhexine hydrochloride and 4.0 ml 
of DMSO. The detection limit (DL) was set at 0.2µg/ml (equivalent to 0.4 
ppm) for benzene, 1 µg/ml (equivalent to 2 ppm) for ethyl acetate and 2.5µg/
ml (equivalent to 5 ppm) for methanol, ethanol and monochlorobenzene. 
The quantitation limit (QL) was set at 75 µg/ml (equivalent to 150 ppm) for 
all RS. Robustness of the method was studied by deliberately varying GC 
parameters such as flow rate, inlet temperature and injector temperature. The 
method robustness was assessed by evaluating the system suitability criteria 
such as sample to noise (S/N) ratio of QL , resolution factor, tailing factor 
and % RSD in assay values compared to the procedural method (as-is) for 
each one of the RS. 
2.8 Calculation
The statistical evaluation of the linearity experiments (correlation coefficient, 
y-intercept, slope of regression line and % of Y – intercept) are carried out by 
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Where r is correlation coefficient, x is first score, y is second score, Σ xy is sum 
of product of first and second score, Σ x  is sum of first score, Σ y is sum of 
second score, Σ
x2
 is sum of squire of first score, Σ
y2
 is sum of squire of second 






score, is squire of sum of first score, is squire of sum of second score and n is 
the number of values or elements.
Y – Intercept has been calculated by – 
 a y bx or y bx a= − = +  (2)
Where is the intercept of the regression line, y is mean of the values at y, x  is 
mean of the values at x and is slope and is calculated from:
 b









and % of y – intercept is calculated by
 Y intercept X100
Mean Area of 100%
−  (4)
Standard deviation and relative standard deviation were calculated by the 
formula given below (Eq-5&6).
 SD = − −S( )x x n 1  (5)
Where SD is standard deviation, x is each value in the sample, x is the mean of 





Where SD is standard deviation RSD is relative standard deviation.
3. RESultS anD DiSCuSSion
3.1 analytical method development
Critical elements of a new HSGC method development are: (i) identifying an 
appropriate diluent (ii) determining suitable headspace parameters (i.e., headspace 
temperature, vial equilibration time, vial pressurization),GC parameters (i.e., 
inlet split ratio, inlet temperature) andGC temperature programming to improve 
the sensitivity of themethod; (iii) determining the detection limit (DL) and 
quantitation limit (QL) levelsbased on the sensitivity of the method.
3.1.1 Selection of solvent for sample preparation
Many organic solvents were investigated, namely, N,N-Dimethylformamide, 1, 
4-dioxane and dimethyl sulfoxide to identify the most suitable solvent (diluent) 
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for the intended purpose of this method. The initial GC oven temperature 
program used was 40 °C for 7 min, at 15°C/min ramp, then to 230 °C and 
hold for 5min. The headspace temperatures were set as 80 °C for oven, 80 °C 
for sample loop, and 85 °C for transfer line to aid the evaporation of the RS 
and to increase the sensitivity. Both N,N-Dimethylformamideand 1, 4-dioxane 
diluent peaks co-eluted with benzene and as such were unsuitable for this 
method. On the other hand, DMSO showed much cleaner chromatograms 
withinsignificant or no interfering peaks in the retention time window of the 
five RS in BHX. Hence DMSO was selected as the diluents for this method 
and all further studies were carried out with DMSO. 
3.1.2 Selection of headspace oven temperature and other  
GC parameters
The headspace sample oven temperature has a profound effecton the sensitivity 
of the method because temperature has a directimpact on the equilibrium 
concentration of the RS in the headspaceof the sample vial (Witschi & Doelker, 
1997). For these experiments, the transfer line was kept 5–10°C higher than 
the sample loop temperature (Yarramraju et al. 2007). Several sample oven 
temperatures were evaluated from 80 to 120 °C with the loop and transfer line 
temperatures changed accordingly but maintained the GC inlet temperature 
at160°C and the split ratio at 20:1. Under these conditions, all theRS were 
detected with an S/N much greater than 10. 
3.1.3 Evaluation of Different GC Parameters
During the preliminary evaluations the GC parameters were set as: GC oven 
temperature was kept at 60°C, flow rate was adjusted to 5 ml/min and hold time 
was 4 min. The runs for this GC program exhibited overlapping for methanol 
and ethanol peaks. Hence a reliable and accurate change in GC parameters was 
extremely required for a good peak separation. To overcome this challenge 
the GC program was varied as oven temperature was set to 40°C, flow rate 
was decreased to 3ml/min and hold time was increased to 7 min. Under these 
conditions a good peak separation for RS methanol and ethanol was observed. 
Final GC and,headspace parameters for the presented HSGC method in this 
work are listedin Table 1.
3.2 analytical method validation
Analytical method validation was carried out with respect to parameter such 
as specificity, accuracy, precision, linearity, DL, QL,robustness and system 
suitability.







The slope, y-intercept and coefficient of correlation were obtained from linear 
regression analysis. The peak area of each individual RS was plotted against 
corresponding theoretical concentrations obtained from each linearity solution. 
The results of statistical evaluation of the linearity experiments are calculated 
by the formula (Eq.1, 2, 3&4) and represented in Table-2. The obtained 
correlation coefficients of linear regression for all solvents were above 0.99. 
These indicate a linear relationship between the concentrations of analytes and 
the response of detector. 
table 2. Results of statistical evaluation of the linearity experiments
Sr. no. name of RS Slope y-intercept Correlation coefficient
% of 
y-intercept
1. Methanol 0.05 21.73 0.995 1.008
2. Ethanol 0.04 24.82 0.996 1.010
3. Ethyl acetate 0.01 98.21 0.999 1.000
4. Benzene 0.10 10.38 0.996 1.000
5. MCB 0.03 33.77 0.993 1.010
3.2.2 Method precision and ruggedness
The precision of the method was established as repeatability, system and 
intermediate precision. For the method precision six replicates of concentration 
of 50 ppm for methanol, ethanol, ethyl acetate, MCB and 2 ppm for benzene of 
mixed standard solution was analyzed. For each solvent, from chromatogram 
peak areas, standard deviation and relative standard deviation for system and 
intermediate precision were calculated by the formula (Eq- 5&6) and given in 
Table-3. For the precision of method and system the % RSD for five solvents 
complies with the acceptance criteria of not more than 15%, hence the method 
and system is said to be précised and has reproducibility.
3.2.3 Detection limit (DL) and quantitation limit (QL)
The sensitivity of the method was demonstrated by detection limit (DL). The 
DL calculated as the concentration, which generated a peak about 3 times 
as high as the height of noise and an average S/N was 47.33, 47.28, 47.27, 
1.71 and 47.33 for methanol, ethanol, ethyl acetate, benzene and MCB. The 
quatitation limit (QL) calculated as the concentration, which generated peak 
about 10 times as high as the height of noise and the average S/N was 143.41, 
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143.27, 143.24, 5.17 and 143.42 for methanol, ethanol, ethyl acetate, benzene 
and MCB.
3.2.4 Method specificity
The method specificity was demonstrated by injecting individual RS which 
showed good separation and resolution between the peaks of the five solvents 
viz., methanol, ethanol, ethyl acetate, benzene and MCB and also the diluents 
(DMSO).  In addition, the diluents blank has no interfering peak that will affect 
the quantitation of the RS in the sample.  
3.2.5 Accuracy and recovery
Accuracy was assessed on samples spiked with known amounts of each five 
solvent (from 80 % to 120 % of specified limit). The accuracy of the method 
was established by measuring nine sample solutions (triplicate preparations 
for solution of 80%, 100% & 120%) against standard solution. The acceptance 
criteria were set up as % RSD value below 10 % and recovery value 100 % 
±10 %. The recovery results are presented in Table-4. The set up criteria were 
fulfilled, thus, the method is accurate.
table 3. Summary of system and intermediate precision






1. Methanol Mean 2191.0 2191.0 2229.1
SD 51.65 51.65 64.97
RSD 2.36 2.36 2.91
2. Ethanol Mean 2585.3 2585.3 2551.2
SD 99.88 99.88 67.48
RSD 3.86 3.86 2.65
3. Ethyl acetate Mean 10096.3 10096.3 10143.7 
SD 177.99 177.99 128.27
RSD 1.76 1.76 1.26
4. Benzene Mean 1286.8 1286.8 1263.1
SD 111.69 111.89 58.08
RSD 8.86 8.86 2.91
5. MCB Mean 3367.5 3367.5 3457.2
SD 79.15 79.15 117.11
RSD 2.35 2.35 3.39






3.2.6 Method robustness: GC parameters variation
In order to evaluate robustness of the method, the influence of variations of 
method parameters such as column flow, injector temperature and column 
oven temperature were investigated. System suitability (SST) requirements 
were checked for variations of conditions, 3.5ml/min on the carrier gas flow, 
35°C on the initial oven temperature and 180°C on the injector temperature. 
For each set of variation, six replicate injections of the standard solution were 
performed. The assay values at different variations were all within ±2% for 
all the five solvents and system suitability criteria were meeting for all the 
variations. The S/N ratios of QL were all above 10.The retention time of all 
RS obtained from parameter variations were within ±1 minute of the retention 
time obtained from the procedural conditions. The obtained results indicate 
that studied variations of GC conditions do not cause any significant changes 
in system suitability and the method is robust for quantitation analysis.
4. ConCluSion
The HS-GC method developed for the identification and quantitationof residual 
methanol, ethanol, ethyl acetate, benzene and monochlorobenzene (MCB) 
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anddiluentDMSOin the samples of BHX API has been successfully validated.
This method has been shown to have a high sensitivity since it has a low DL of 
0.4 ppm for benzene, 2 ppm for ethyl acetate and 5 ppm for methanol, ethanol 
and MCB.The validation procedure, carried out according to ICH guidelines 
Q2A and Q2B, specificity, precision, accuracy, limits of detection and 
quantitation and robustness were evaluated. All set up criteria were fulfilled. 
The method is specific, accurate, and linear and shows a satisfactory level of 
precision. The developed and validation procedure shows that the method is 
suitable for its intended purpose.
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